| 中文名称： | Adjudin | 中文别名： | Adjudin |
|---|---|---|---|
| 英文名称： | Adjudin | CAS： | 252025-52-8 |
| 产品分类： | 小分子化合物 | 纯度： | ≥98% |
| 产品编号 | 品牌 | 纯度 | 规格 | 库存 | 价格 |
|---|---|---|---|---|---|
| IA0760 | 索莱宝 | ≥98% | 5mg | 有现货 | 690.00 元 |
| IA0760 | 索莱宝 | ≥98% | 10mg | 有现货 | 1,110.00 元 |
| IA0760 | 索莱宝 | ≥98% | 1mg | 有现货 | 300.00 元 |
| IA0760 | 索莱宝 | ≥98% | 25mg | 有现货 | 2,140.00 元 |
| IA0760 | 索莱宝 | ≥98% | 50mg | 有现货 | 3,350.00 元 |
| 标准名称: | 男用口服避孕药 | 英文名称： | Adjudin |
|---|---|---|---|
| CAS： | 252025-52-8 | 分子式： | C15H12Cl2N4O |
| 分子量： | 335.187980651855 | 颜色与性状： | |
| 密度： | 1.51±0.1 g/cm3 (20 ºC 760 Torr), | 沸点： | |
| 熔点： | 水溶性： |
| CAS | 252025-52-8 |
| 英文名称 | Adjudin |
| 别名 | AF-2364;SCM-198hydrochloride;AF-2364Hydroferulicacid |
| 分子式 | C15H12Cl2N4O |
| 分子量 | 335.19 |
| 规格 | 5mg ; 10mg ; 1mg ; 25mg ; 50mg |
| 溶解性 | Soluble in DMSO |
| 纯度 | ≥98% |
| 级别 | Cell Culture |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| 运输条件 | 冷藏运输 |
| SMILES | O=C(C1=NN(CC2=CC=C(Cl)C=C2Cl)C3=C1C=CC=C3)NN |
| InChIKey | VENCPJAAXKBIJD-UHFFFAOYSA-N |
| InChI | InChI=1S/C15H12Cl2N4O/c16-10-6-5-9(12(17)7-10)8-21-13-4-2-1-3-11(13)14(20-21)15(22)19-18/h1-7H,8,18H2,(H,19,22) |
| PubChem CID | 9819086 |
| 靶点 | Chloride Channel |
| 通路 | Membrane Transporter&Ion Channel |
| 背景说明 | Adjudin是一种有效的 Cl channels 的阻滞剂, 能够抑制 NF-κB p65核易位和DNA结合活性。 |
| 生物活性 | Adjudin is an extensively studied male contraceptive with a superior mitochondria-inhibitory effect. Adjudin is also a potent Cl- channel blocker.[1-2] |
| In Vitro | Adjudin is a potent blocker of Cl- channels: disrupting Cl- ion transport function results in a decline in sperm capacitation and fertilizing ability in humans in vitro[1]. Adjudin(ADD)is a mitochondria inhibitor[2]. Adjudin is a molecule that mediates adherens junction disruption at the Sertoli-germ cell interface. To investigate the effect of Adjudin on cancer cells，more than ten different types of human or mice cancer cell lines are treated with increasing concentrations of Adjudin and the cell proliferation is measured by the modified MTT assay. Adjudin inhibits cell proliferation in a dose dependent manner in SGC-7901(human gastric adenocarcinoma cell)，MDA-MB-231(human breast adenocarcinoma cell)，Smmc-7721(human hepatoma cell)and MIA Paca-2(human pancreatic adenocarcinoma cell)cells. The IC50 of Adjudin is determined to be 58.0 μM，13.8 μM，72.3 μM and 52.7 μM against SGC-7901，MDA-MB-231，Smmc-7721 and MIA Paca-2 cells，respectively，after treatment for 24 h. Similar results are obtained in other human and mice cancer cell lines. The IC50 of Adjudin in A549 cells and PC3 cells is 63.1 μM and 93.0 μM，respectively. For WI-38 and BPH-1 cells，the IC50 of Adjudin can be observed at more than 300 μM and 200 μM，respectively，which is about 5 times and 2 times more than that for the cancer cell lines A549 and PC3[3]. |
| In Vivo | To determine whether Adjudin can inhibit lung and prostate cancer growth in vivo，the effect of Adjudin is tested in a subcutaneous model of lung and prostate cancer. Human lung carcinoma cells A549 and prostate carcinoma cells PC3 are injected into athymic nude mice subdermally at the lower back site respectively. Mice are then randomized into two treatment groups with similar mean tumor sizes: Adjudin and vehicle(control). Approximately 2 weeks after tumor inoculation Adjudin is injected intraperitoneally once every three days in lung carcinoma cells and every other day in prostate carcinoma cells at 100 mg/kg. Adjudin treatment can be well tolerated in rodent. And Adjudin-treated mice show significant tumor growth inhibition compared with the control group(P<0.0001 in the human lung carcinoma cells A549 and P=0.006 in the prostate carcinoma cells PC3)[3]. |
| 数据来源文献 | [1]. Li K， et al. Inhibition of sperm capacitation and fertilizing capacity by adjudin is mediated by chloride and its channels in humans. Hum Reprod. 2013 Jan;28(1):47-59. [2]. Li X， et al. Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells. J Mater Chem B. 2015 Feb 28;3(8):1556-1564. [3]. Xie QR， et al. Male contraceptive Adjudin is a potential anti-cancer drug. Biochem Pharmacol. 2013 Feb 1;85(3):345-55. |
| 单位 | 瓶 |
| 1mM-5mg | 14.9169mL |
| 1mM-1mg | 2.9834mL |
| 1mM-10mg | 29.8338mL |
| 5mM-1mg | 0.5967mL |
| 5mM-5mg | 2.9834mL |
| 5mM-10mg | 5.9668mL |
| 10mM-1mg | 0.2983mL |
| 10mM-5mg | 1.4917mL |
| 10mM-10mg | 2.9834mL |
公司拥有一批专业的研发人员，我们专注于生物产品的不断完善和创新。产品覆盖面广，品质可靠。先后开发了涵盖分子生物学、细胞生物学、免疫学、生物医学等领域的多种试剂及试剂盒。同时，索莱宝公司提供各种常规生化试剂，库存常备产品多达10000多种，可随时为广大科研工作者提供各类专业试剂。在质量方面，索莱宝谨记公司信念：质量高于一切。所有研发的产品都设有严谨的生产流程，科学的质量检测方法和成熟的质量检测程序，我们恪守对每一位用户的承诺：用专业的态度做专业的品牌。同时，公司组建了一支专业的技术服务队伍，能够为科研工作者提供专业的技术服务。每一位购买索莱宝产品的用户都能够得到专业的咨询和完善的售后服务。
索莱宝公司坚持与国际接轨，注重和国际先进企业的合作与交流，并提供产品代理、市场咨询等多项服务。公司将一如既往与世界更多知名品牌合作，不断为广大生物科研工作者提供更优质的产品和服务。公司理念：“为科研服务，为生命尽责”。一个人能够走多远，取决于与谁同行。索莱宝公司期待与各同行精诚合作。
索莱宝诚招生物试剂研发人员，期待与广大同行精诚合作，为广大科研工作者提供优质的产品，高效的物流以及专业的售后服务。索莱宝感谢所有朋友的支持与帮助，您的支持是我们前进的动力和保障。让我们携手同行，共同创造美好的明天。
| 企业认证： | 已认证 | 企业性质： | 生产研发 |
|---|---|---|---|
| 主营产品： | 氢化可的松17-戊酸酯 ； 阿氯米松双丙酸酯 标准品 ； 醋酸氯地孕酮 ； 3β-熊去氧胆酸 ； 瑞舒伐他汀钙(10mM in DMSO，无菌) ； | 供货范围： | 试剂 |
| 产品目录： | 119904 | 品牌： | 索莱宝 |
| 纯度 | 品牌 | 规格 | 发货地 |
|---|---|---|---|
| HPLC≥98% | 索莱宝 | 50mg | 北京 |
| 纯度 | 品牌 | 规格 | 发货地 |
|---|---|---|---|
| HPLC≥98% | 索莱宝 | 5mg | 北京 |
商务合作对接
关注官方微信公众号
微信扫码联系客服
